Reference number : 236-2018-2019-Q3-00502, amendment number : , agreement type : G, recipient legal name : Hughes, Avery, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : H3C 3J7, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 750.0, agreement start date : 2018-10-01, agreement end date : 2019-09-30, description english : Biosimilar Infliximab Compared to Reference Infliximab in Adults with Crohn's Disease: A Cost-Utility Analysis, description french : Biosimilar Infliximab Compared to Reference Infliximab in Adults with Crohn's Disease: A Cost-Utility Analysis, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada